Yungjin Pharm영진약품
003520 · KOSPI · ₩003520 · 영진약품
₩951▼ ₩4 (0.42%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Oct 8, 2026Open on DART
- Lawsuit filed or ruled소송등의제기ㆍ신청(일정금액이상의청구)Sep 1, 2026Open on DART
- Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Aug 28, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation Bodies지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항Aug 13, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Aug 12, 2026Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)Jul 31, 2026Open on DART
- [Corrected] New Facility Investment, etc.[기재정정]신규시설투자등Jul 24, 2026Open on DART
- Disclosure of Large Business Group Status [Annual Disclosure and Q1 Use (Individual Companies)]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]Jun 1, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시May 28, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)May 6, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 20, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 20, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 12, 2026Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 5, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 5, 2026Open on DART
- Audit report submitted감사보고서제출Mar 3, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 27, 2026Open on DART
- Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Feb 27, 2026Open on DART
- Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation Bodies지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항Feb 11, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jan 19, 2026Open on DART
- Lawsuit filed or ruled소송등의판결ㆍ결정(일정금액이상의청구)Jan 19, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 16, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항Dec 22, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Results of Rights Offering or Issuance of Equity-Linked Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의발행결과(자율공시)Nov 28, 2025Open on DART
- Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Nov 28, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Nov 20, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)Nov 5, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Oct 2, 2025Open on DART
- Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]대규모기업집단현황공시[분기별공시(개별회사용)]Aug 28, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Amended: Quarterly report (Mar 2025)[기재정정]분기보고서 (2025.03)Aug 14, 2025Open on DART
- Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Aug 14, 2025Open on DART
- Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation Bodies지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항Aug 13, 2025Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)Aug 1, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Jul 31, 2025Open on DART
- [Corrected] New Facility Investment, etc.[기재정정]신규시설투자등Jul 25, 2025Open on DART
- Disclosure of Large Business Group Status [Annual Disclosure and Q1 Use (Individual Companies)]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]May 30, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Preliminary earnings영업(잠정)실적(공정공시)May 7, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 28, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Yungjin Pharm / 영진약품 / 003520 / KRX:003520
Source: KRX statistical information